OikawaS., ImaiM., UenoA.Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide. Nature1984; 309: 724–6.
2.
LangR.E., UngerT., GantenD.. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertension1987; 5: 255–9.
3.
RaineA.E.G., ErneP., BürgisserE.Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med1986; 315: 533–7.
4.
WeidmannP., HellmuellerB., UehlingerD.E.Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab1986; 62: 1027–36.
5.
WeselcouchE.O., HumphreyW.R., AikenJ.W.. Effect of pulmonary and renal circulations on activity of atrial natriuretic factor. Am J Physiol1985; 249: R595–602.
6.
LaraghJ.H.. Atrial natriuretic hormone, the renin-aldosterone axis, and the blood pressure-electrolyte homeostasis. N Engl J Med1985; 313: 1330–73.
7.
NgK.K.F., VaneF.R.. Conversion of angiotensin I to angiotensin II. Nature1967; 216: 168–73.
8.
RomerF.K.. Angiotension-converting enzyme and its association with outcome in lung cancer. Br J Cancer1981; 43: 135–42.
9.
MansfieldC.M., KimlerB.F., HendersonS.D., VatsT.S., SvobodaD.J.. Angiotensin-I-converting enzyme in cancer patients. J Clin Oncol1984; 2: 452–6.